NCT02908152View on ClinicalTrials.gov

Curcumin Supplement in Nonalcoholic Fatty Liver Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 10, 2017

Primary Completion Date

July 10, 2017

Study Completion Date

October 10, 2017

Conditions
Type 2 DiabetesNonalcoholic Fatty Liver
Interventions
DIETARY_SUPPLEMENT

curcumin

"1500 mg~1 capsule / day for 12 weeks"

DIETARY_SUPPLEMENT

placebo

"1500 mg~1 capsule / day for 12 weeks"

Trial Locations (1)

Unknown

NNFTRI, Tehran

All Listed Sponsors
lead

National Nutrition and Food Technology Institute

OTHER

NCT02908152 - Curcumin Supplement in Nonalcoholic Fatty Liver Patients | Biotech Hunter | Biotech Hunter